Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Neuroinflammation|April 17, 2024
IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onsetKevin Budding, Jeroen W Bos, Kim Dijkxhoorn, et al.
Brain : a Journal of Neurology|February 9, 2022
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathyMax E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, et al.
Journal of the Peripheral Nervous System : JPNS|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.
Brain Communications|January 12, 2023
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4Marloes Stam, Camiel A Wijngaarde, Bart Bartels, et al.
European Journal of Neurology|September 5, 2024
Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseasesKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Neurology. Clinical Practice|April 12, 2021
Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and PathophysiologyEva M J de Boer, Andrew W Barritt, Marwa Elamin, et al.
Brain Communications|September 21, 2020
<i>ATXN1</i> repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalizationGijs H P Tazelaar, Steven Boeynaems, Mathias De Decker, et al.
Pageof 9